Press Releases : Assembly Biosciences, Inc.

Press Releases

Nov 12, 2021	Assembly Biosciences Presents New Data at AASLD The Liver Meeting™ Highlighting the Progress of its HBV Core Inhibitor Portfolio	View HTML PDF Version
Nov 04, 2021	Assembly Biosciences Reports Third Quarter 2021 Financial Results and Recent Highlights	View HTML PDF Version
Nov 01, 2021	Assembly Biosciences Abstracts Selected for Presentation at the Upcoming AASLD The Liver Meeting®	View HTML PDF Version
Oct 19, 2021	Antios Therapeutics and Assembly Biosciences Announce Clinical Collaboration Agreement to Evaluate the Combination of ATI-2173 and Vebicorvir in Patients with Chronic Hepatitis B Virus Infection	View HTML PDF Version
Oct 06, 2021	Assembly Bio Announces October Conference Participation	View HTML PDF Version
Oct 01, 2021	Assembly Biosciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)	View HTML PDF Version
Sep 01, 2021	Assembly Bio Announces Decision to Discontinue Clinical Development of ABI-H2158	View HTML PDF Version
Aug 18, 2021	Assembly Bio Selects Fourth HBV Core Inhibitor Candidate for Advancement Into Clinical Development	View HTML PDF Version
Aug 05, 2021	Assembly Biosciences Reports Second Quarter 2021 Financial Results and Recent Highlights	View HTML PDF Version
Aug 03, 2021	Assembly Bio Announces Key Promotions to Leadership Team	View HTML PDF Version

Shareholder Tools

Search Investors